These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 33662027)

  • 1. Differential responses to folic acid in an established keloid fibroblast cell line are mediated by JAK1/2 and STAT3.
    McCann KJ; Yadav M; Alishahedani ME; Freeman AF; Myles IA
    PLoS One; 2021; 16(3):e0248011. PubMed ID: 33662027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Green tea polyphenol epigallocatechin-3-gallate suppresses collagen production and proliferation in keloid fibroblasts via inhibition of the STAT3-signaling pathway.
    Park G; Yoon BS; Moon JH; Kim B; Jun EK; Oh S; Kim H; Song HJ; Noh JY; Oh C; You S
    J Invest Dermatol; 2008 Oct; 128(10):2429-41. PubMed ID: 18463684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic reprogramming in keloid fibroblasts: Aerobic glycolysis and a novel therapeutic strategy.
    Li Q; Qin Z; Nie F; Bi H; Zhao R; Pan B; Ma J; Xie X
    Biochem Biophys Res Commun; 2018 Feb; 496(2):641-647. PubMed ID: 29337061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine receptor signaling is required for the survival of ALK- anaplastic large cell lymphoma, even in the presence of JAK1/STAT3 mutations.
    Chen J; Zhang Y; Petrus MN; Xiao W; Nicolae A; Raffeld M; Pittaluga S; Bamford RN; Nakagawa M; Ouyang ST; Epstein AL; Kadin ME; Del Mistro A; Woessner R; Jaffe ES; Waldmann TA
    Proc Natl Acad Sci U S A; 2017 Apr; 114(15):3975-3980. PubMed ID: 28356514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stat3 contributes to keloid pathogenesis via promoting collagen production, cell proliferation and migration.
    Lim CP; Phan TT; Lim IJ; Cao X
    Oncogene; 2006 Aug; 25(39):5416-25. PubMed ID: 16619044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TSP1 promotes fibroblast proliferation and extracellular matrix deposition via the IL6/JAK2/STAT3 signalling pathway in keloids.
    Feng QL; Gu JJ; Chen JY; Zheng WY; Pan HH; Xu XY; Deng CC; Yang B
    Exp Dermatol; 2022 Oct; 31(10):1533-1542. PubMed ID: 35661430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The JAK1/JAK2- inhibitor ruxolitinib inhibits mast cell degranulation and cytokine release.
    Hermans MAW; Schrijver B; van Holten-Neelen CCPA; Gerth van Wijk R; van Hagen PM; van Daele PLA; Dik WA
    Clin Exp Allergy; 2018 Nov; 48(11):1412-1420. PubMed ID: 29939445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. JAK1-dependent transphosphorylation of JAK2 limits the antifibrotic effects of selective JAK2 inhibitors on long-term treatment.
    Zhang Y; Liang R; Chen CW; Mallano T; Dees C; Distler A; Reich A; Bergmann C; Ramming A; Gelse K; Mielenz D; Distler O; Schett G; Distler JHW
    Ann Rheum Dis; 2017 Aug; 76(8):1467-1475. PubMed ID: 28478401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery and evaluation of Atopaxar hydrobromide, a novel JAK1 and JAK2 inhibitor, selectively induces apoptosis of cancer cells with constitutively activated STAT3.
    Sun J; Du Y; Zhang X; Wang Z; Lin Y; Song Q; Wang X; Guo J; Li S; Nan J; Yang J
    Invest New Drugs; 2020 Aug; 38(4):1003-1011. PubMed ID: 31612426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-17 Induced Stromal Cell-Derived Factor-1 and Profibrotic Factor in Keloid-Derived Skin Fibroblasts via the STAT3 Pathway.
    Lee SY; Kim EK; Seo HB; Choi JW; Yoo JH; Jung KA; Kim DS; Yang SC; Moon SJ; Lee JH; Cho ML
    Inflammation; 2020 Apr; 43(2):664-672. PubMed ID: 31814061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical evaluation of local JAK1 and JAK2 inhibition in cutaneous inflammation.
    Fridman JS; Scherle PA; Collins R; Burn T; Neilan CL; Hertel D; Contel N; Haley P; Thomas B; Shi J; Collier P; Rodgers JD; Shepard S; Metcalf B; Hollis G; Newton RC; Yeleswaram S; Friedman SM; Vaddi K
    J Invest Dermatol; 2011 Sep; 131(9):1838-44. PubMed ID: 21677670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sorafenib exerts an anti-keloid activity by antagonizing TGF-β/Smad and MAPK/ERK signaling pathways.
    Wang W; Qu M; Xu L; Wu X; Gao Z; Gu T; Zhang W; Ding X; Liu W; Chen YL
    J Mol Med (Berl); 2016 Oct; 94(10):1181-1194. PubMed ID: 27339758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of fibroblast activation protein-alpha in keloid fibroblasts: implications for development of a novel treatment option.
    Dienus K; Bayat A; Gilmore BF; Seifert O
    Arch Dermatol Res; 2010 Dec; 302(10):725-31. PubMed ID: 20872224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of JAK1/2 Tyrosine Kinases Reduces Neurogenic Heterotopic Ossification After Spinal Cord Injury.
    Alexander KA; Tseng HW; Fleming W; Jose B; Salga M; Kulina I; Millard SM; Pettit AR; Genêt F; Levesque JP
    Front Immunol; 2019; 10():377. PubMed ID: 30899259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of genistein ability to modulate CTGF mRNA/protein expression, genes expression of TGFβ isoforms and expression of selected genes regulating cell cycle in keloid fibroblasts in vitro.
    Jurzak M; Adamczyk K; Antończak P; Garncarczyk A; Kuśmierz D; Latocha M
    Acta Pol Pharm; 2014; 71(6):972-86. PubMed ID: 25745770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. INCB16562, a JAK1/2 selective inhibitor, is efficacious against multiple myeloma cells and reverses the protective effects of cytokine and stromal cell support.
    Li J; Favata M; Kelley JA; Caulder E; Thomas B; Wen X; Sparks RB; Arvanitis A; Rogers JD; Combs AP; Vaddi K; Solomon KA; Scherle PA; Newton R; Fridman JS
    Neoplasia; 2010 Jan; 12(1):28-38. PubMed ID: 20072651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The JAK2/STAT3 pathway inhibitor, AG490, suppresses the abnormal behavior of keloid fibroblasts in vitro.
    Zhou Y; Sun Y; Hou W; Ma L; Tao Y; Li D; Xu C; Bao J; Fan W
    Int J Mol Med; 2020 Jul; 46(1):191-200. PubMed ID: 32377718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-17 Induces Autophagy Dysfunction to Promote Inflammatory Cell Death and Fibrosis in Keloid Fibroblasts
    Lee SY; Lee AR; Choi JW; Lee CR; Cho KH; Lee JH; Cho ML
    Front Immunol; 2022; 13():888719. PubMed ID: 35757697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. JAK kinase inhibition abrogates STAT3 activation and head and neck squamous cell carcinoma tumor growth.
    Sen M; Pollock NI; Black J; DeGrave KA; Wheeler S; Freilino ML; Joyce S; Lui VW; Zeng Y; Chiosea SI; Grandis JR
    Neoplasia; 2015 Mar; 17(3):256-64. PubMed ID: 25810010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adiponectin Is Involved in Connective Tissue Growth Factor-Induced Proliferation, Migration and Overproduction of the Extracellular Matrix in Keloid Fibroblasts.
    Luo L; Li J; Liu H; Jian X; Zou Q; Zhao Q; Le Q; Chen H; Gao X; He C
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28498357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.